Skip to main content
. 2013 Dec 18;306(3):R157–R163. doi: 10.1152/ajpregu.00358.2013

Fig. 4.

Fig. 4.

Within-subject percent suppression in blood glucose concentrations compared with vehicle-0.9% NaCl treatment after intraduodenal infusions of MPC or soy protein with (B) and without (A) sitagliptin administration. Between-subject analyses of this percent suppression shows that the combination of MPC with sitagliptin produced a significantly increased percent suppression in blood glucose compared with soy protein and sitagliptin administration at 40 min (P < 0.05).